Federal Health Policy: How It May Affect Your Oncology Program

Oncology professionals are working in an increasingly complex economic landscape. From new reimbursement models and the site-neutral payment policy, to trends in drug pricing and ongoing changes under the 340B Drug Pricing Program, take a practical look at how these policies may impact your bottom line and how you can make better-informed decisions when it comes to short- and long-term strategic planning.

Specific learning objectives for this webinar include:

• Understand recent and ongoing regulatory changes within the oncology industry.
• Review how these developments will impact the financial performance of your oncology program.
• Discuss approaches for evolving your approach to care delivery to ensure long-term success.

This webinar was presented by Jennifer Bell, founding partner at Chamber Hill Strategies, as well as Matthew Sturm and Lili Hay, members of ECG’s oncology strategic planning team.